HSI1 26,163.24 0.00 --
HSCEI1 8,801.78 0.00 --
Back    Zoom +    Zoom - Block Traded
HENGRUI PHARMA Sees 21.78% YoY Growth in 1Q NP Attributable to Shareholders
2026-04-22 17:55:56
HENGRUI PHARMA (01276.HK) announced that its operating revenue for 1Q26 rose by 12.98% YoY to RMB8.141 billion, while net profit attributable to its shareholders increased by 21.78% YoY to RMB2.282 billion, with basic EPS of RMB0.34.
~



AAStocks Financial News
Web Site: www.aastocks.com